has retatrutide been approved vs. Tirzepatide: What's the Difference? Trial of next-gen weight-loss drug

Research supporting GLP-1 receptor agonist therapy demonstrates that adherence to the prescribed regimen is strongly associated with improved HbA1c reduction and sustained weight management benefits

(Victoza contains the same active ingredient as Saxenda but is used for Type 2 diabetes and cardiovascular risk reduction.) Other Saxenda alternatives include Ozempic (semaglutide), Mounjaro (tirzepatide), metformin, Qsymia (phentermine/topiramate), and Contrave (naltrexone/bupropion)

States may offer broader coverage but cannot make coverage criteria more restrictive, and the Medicaid key terms must apply equally in both fee-for-service and Medicaid managed care

Collaborators GBDAB

Lamour, V., Kaplan, M